Search results for "41"

showing 10 items of 3365 documents

Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy.

2021

Gene-directed enzyme prodrug therapy (GDEPT) has been intensively studied as a promising new strategy of prodrug delivery, with its main advantages being represented by an enhanced efficacy and a reduced off-target toxicity of the active drug. In recent years, numerous therapeutic systems based on GDEPT strategy have entered clinical trials. In order to deliver the desired gene at a specific site of action, this therapeutic approach uses vectors divided in two major categories, viral vectors and non-viral vectors, with the latter being represented by chemical delivery agents. There is considerable interest in the development of non-viral vectors due to their decreased immunogenicity, higher…

DrugDendrimersmedicine.medical_treatmentmedia_common.quotation_subjectGenetic VectorsPharmaceutical ScienceEnzyme TherapyComputational biologyReviewdendrimerdelivery vehiclesAnalytical ChemistryTargeted therapyViral vectornon-viral vectorQD241-441DendrimerGDEPTDrug DiscoverymedicineAnimalsHumansProdrugsPhysical and Theoretical ChemistryGenemedia_commonchemistry.chemical_classificationGDEP therapyImmunogenicityOrganic ChemistrytransgeneGene Transfer TechniquesGenetic TherapyProdrugtargeted therapyEnzymesEnzymechemistrygene delivery systemChemistry (miscellaneous)Molecular MedicineNanoparticlesMolecules (Basel, Switzerland)
researchProduct

A Colorimetric Membrane-Based Sensor with Improved Selectivity towards Amphetamine

2021

Due to their simplicity, speed and low cost, chemical spot tests are increasingly demanded for the presumptive identification of illicit drugs in a variety of contexts such as point-of-care assistance or prosecution of drug trafficking. However, most of the colorimetric reactions used in these tests are, at best, drug class selective. Therefore, the development of tests based on chemical reactions with improved discrimination power is of great interest. In this work, we propose a new colorimetric assay for amphetamine (AMP) based on its reaction with solutions of alkaline gold bromide to form an insoluble yellow–orange derivative. The resulting suspensions are then filtered onto nylon membr…

DrugDiffuse reflectance infrared fourier transformmedia_common.quotation_subjectamphetaminePharmaceutical Sciencegold bromideBiosensing TechniquesSensitivity and Specificitycolorimetric sensorsArticleAnalytical ChemistryAbsorbancechemistry.chemical_compoundQD241-441BromideSpectroscopy Fourier Transform InfraredDrug DiscoverymedicinePhysical and Theoretical ChemistryEphedrineAmphetaminemedia_commonChromatographyIllicit DrugsOrganic ChemistryReproducibility of Resultsdrug analysisSubstance Abuse DetectionMembranechemistryChemistry (miscellaneous)Molecular MedicineColorimetryillicit drug samplesSelectivitymedicine.drugMolecules
researchProduct

Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat

2020

Sufficient colonic absorption is necessary for all systemically acting drugs in dosage forms that release the drug in the large intestine. Preclinically, colonic absorption is often investigated using the rat single-pass intestinal perfusion model. This model can determine intestinal permeability based on luminal drug disappearance, as well as the effect of permeation enhancers on drug permeability. However, it is uncertain how accurate the rat single-pass intestinal perfusion model predicts regional intestinal permeability and absorption in human. There is also a shortage of systematic in vivo investigations of the direct effect of permeation enhancers in the small and large intestine. In …

DrugKetoprofenmedia_common.quotation_subjectlcsh:RS1-441Pharmaceutical ScienceGastroenterology and Hepatology02 engineering and technologyPharmacology030226 pharmacology & pharmacyArticleDosage formlcsh:Pharmacy and materia medicaJejunumPharmaceutical Sciences03 medical and health sciences0302 clinical medicineabsorption-modifying excipientsintestinal perfusionIn vivoGastroenterologimedicineLarge intestineregional intestinal permeabilitymedia_commonIntestinal permeabilityChemistrypermeation enhancersPermeationFarmaceutiska vetenskaper021001 nanoscience & nanotechnologymedicine.diseasepharmaceutical developmentmedicine.anatomical_structureoral peptide delivery0210 nano-technologymedicine.drugPharmaceutics
researchProduct

Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Phar…

2011

The renin-angiotensin-aldosterone system (RAAS) plays a dominant role in the pathophysiology of hypertension, diabetes mellitus, chronic kidney disease and chronic heart failure. Therefore, drugs that block key components of the RAAS such as ACE inhibitors (ACEI) and angiotensin receptor blockers (ARBs) have gained wide clinical use for these indications. Despite progress, the morbidity and mortality of patients treated with ACEI or ARBs remain high. Aliskiren (Tekturna, Rasilez) is the first orally active inhibitor of renin approved for clinical use as an antihypertensive agent. The development program has established that at the licensed doses of 150 mg and 300 mg. Aliskiren is effective …

DrugRamiprilbusiness.industrymedia_common.quotation_subjectlcsh:RPharmaceutical ScienceCorrectionlcsh:Medicinelcsh:RS1-441AliskirenPharmacologylcsh:Pharmacy and materia medicachemistry.chemical_compoundIrbesartanAliskiren 300 MGn/achemistryDrug DiscoverymedicineMolecular MedicineDosing intervalbusinessmedia_commonmedicine.drugPharmaceuticals
researchProduct

Solid and Semisolid Innovative Formulations Containing Miconazole-Loaded Solid Lipid Microparticles to Promote Drug Entrapment into the Buccal Mucosa

2021

The currently available antifungal therapy for oral candidiasis (OC) has various limita- tions restricting its clinical use, such as short retention time, suboptimal drug concentration and low patients compliance. These issues could be overcome using micro or nanotechnology. In par- ticular, solid lipid microparticles (SLMs) resulted as a particularly promising penetration enhancer carrier for lipophilic drugs, such as the antifungal miconazole (MCZ). Based on these considera- tions, cetyl decanoate (here synthesized without the use of metal catalysis) was employed together with 1-hexadecanol to prepare MCZ-loaded SLMs. These resulted in a powder composed of 45–300 µm diameter solid spheric…

Drugbuccal filmmedia_common.quotation_subjectPharmaceutical SciencemiconazoleBuccal mucosaArticleDosage formbuccal gelEntrapmentPharmacy and materia medicaoral candidiasismedicineex vivo studiemedia_commonChromatographycetyl decanoateChemistryex vivo studiesBuccal administrationPermeationoral candidiasiRS1-441mucosal deliverySettore CHIM/09 - Farmaceutico Tecnologico Applicativopenetration enhancersolid lipid microparticlebuccal mucosasolid lipid microparticlesMiconazoleEx vivomedicine.drugPharmaceutics
researchProduct

Influence of Chemical Enhancers and Iontophoresis on the In Vitro Transdermal Permeation of Propranolol: Evaluation by Dermatopharmacokinetics

2018

[EN] The aims of this study were to assess, in vitro, the possibility of administering propranolol transdermally and to evaluate the usefulness of the dermatopharmacokinetic (DPK) method in assessing the transport of drugs through stratum corneum, using propranolol as a model compound. Four chemical enhancers (decenoic and oleic acid, laurocapram, and R-(+)-limonene) and iontophoresis at two current densities, 0.25 and 0.5 mA/cm(2) were tested. R-(+)-limonene, and iontophoresis at 0.5 mA/cm(2) were proven to be the most efficient in increasing propranolol transdermal flux, both doubled the original propranolol transdermal flux. Iontophoresis was demonstrated to be superior than the chemical…

Drugdermatopharmacokineticsmedia_common.quotation_subjectChemical enhancerslcsh:RS1-441Pharmaceutical SciencePropanol - Uso terapéutico.02 engineering and technologyPropranololMedicamentos - Administración.030226 pharmacology & pharmacyArticlelcsh:Pharmacy and materia medicaIonización.03 medical and health sciences0302 clinical medicineIonization.medicineStratum corneumpropranololDermatopharmacokineticsTransdermalmedia_commonchemical enhancersChromatographytransdermal administrationIontophoresisChemistryLaurocapramTransdermal administrationIontophoresisDrugs - Administration.Skin absorption.iontophoresisPermeation021001 nanoscience & nanotechnologyPropranololPropanol - Therapeutic use.In vitromedicine.anatomical_structurePropanol - Pharmacokinetics.Propanol - Farmacocinética.Absorción cutánea.0210 nano-technologymedicine.drugPharmaceutics
researchProduct

Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles

2021

Atopic dermatitis (AD) and psoriasis are the most common chronic inflammatory skin disorders, which importantly affect the quality of life of patients who suffer them. Among other causes, nitric oxide has been reported as part of the triggering factors in the pathogenesis of both conditions. Cyanocobalamin (vitamin B12) has shown efficacy as a nitric oxide scavenger and some clinical trials have given positive outcomes in its use for treating skin pathologies. Passive skin diffusion is possible only for drugs with low molecular weights and intermediate lipophilicity. Unfortunately, the molecular weight and hydrophilicity of vitamin B12 do not predict its effective diffusion through the skin…

Drugliposomesmedia_common.quotation_subjectPharmaceutical Sciencelcsh:RS1-441Dermatitis02 engineering and technologyPharmacology030226 pharmacology & pharmacyArticleNitric oxidelcsh:Pharmacy and materia medica03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePsoriasismedicineCyanocobalaminVitamin B12cyanocobalaminskin topical deliverymedia_commonLiposomeatopic dermatitisVesiclePellAtopic dermatitisvitamin B12psoriasis021001 nanoscience & nanotechnologymedicine.diseaselipid vesicleschemistrytransferosomes0210 nano-technologyTecnologia farmacèuticaPharmaceutics
researchProduct

Induction of Drug Transporters Alters Disposition of Risperidone - A Study in Mice

2010

Pharmacokinetic interactions, e.g. modulation of drug transporters like P-glycoprotein at the blood-brain barrier, can be a reason for treatment non-response. This study focuses on the influence of induction of drug transporters on the disposition of the antipsychotic drugs risperidone and 9-hydroxyrisperidone. Brain and serum concentrations of risperidone and its active metabolite 9-hydroxyrisperidone, which are known P-glycoprotein substrates, were measured after drug transporter induction with rifampicin, dexamethasone or 5-pregnene-3beta-ol-20-on-16alpha-carbonitrile using high performance liquid chromatography. Disposition of risperidone and 9-hydroxyrisperidone was dramatically decrea…

Drugmedia_common.quotation_subjectmedicine.medical_treatmentlcsh:RS1-441Pharmaceutical ScienceP-glycoproteinPharmacologyArticlelcsh:Pharmacy and materia medicaPharmacokineticsMedicineAntipsychoticDexamethasoneActive metaboliteP-glycoproteinmedia_commonrisperidoneRisperidonebiologybusiness.industryTransporterdrug transporterantipsychoticsdispositionbiology.protein9-hydroxyrisperidonebusinessmedicine.drugPharmaceutics
researchProduct

Slow Relaxation of the Magnetization in Anilato-Based Dy(III) 2D Lattices.

2021

The search for two- and three-dimensional materials with slow relaxation of the magnetization (single-ion magnets, SIM and single-molecule magnets, SMM) has become a very active area in recent years. Here we show how it is possible to prepare two-dimensional SIMs by combining Dy(III) with two different anilato-type ligands (dianions of the 3,6-disubstituted-2,5-dihydroxy-1,4-benzoquinone: C6O4X22−, with X = H and Cl) in dimethyl sulfoxide (dmso). The two compounds prepared, formulated as: [Dy2(C6O4H2)3(dmso)2(H2O)2]·2dmso·18H2O (1) and [Dy2(C6O4Cl2)3(dmso)4]·2dmso·2H2O (2) show distorted hexagonal honeycomb layers with the solvent molecules (dmso and H2O) located in the interlayer space and…

Dy(III)Models Molecularhoneycomb structureMaterials sciencePharmaceutical ScienceCrystal structureArticleAnalytical Chemistrylcsh:QD241-441chemistry.chemical_compoundMagnetizationFI-SIMlcsh:Organic chemistryCoordination ComplexesDrug DiscoveryBenzoquinonesDysprosiumMoleculePhysical and Theoretical ChemistryMolecular StructureDimethyl sulfoxideOrganic ChemistryRelaxation (NMR)SIMSMMSolventCrystallographychemistrylayered materialsChemistry (miscellaneous)MagnetMolecular MedicineDerivative (chemistry)anilato ligandsMolecules (Basel, Switzerland)
researchProduct

Nutraceuticals and dyslipidaemia: Beyond the common therapeutics

2014

Dyslipidaemia accelerates the atherosclerotic process and its morbid consequences; statins represent the evidence-based treatment of choice for reducing low-density lipoprotein cholesterol levels and decreasing cardiovascular events. Unfortunately, statins are frequently not available for several reasons, including intolerance, side effects or, simply, patient preference. Nutraceuticals and functional food ingredients that are beneficial to vascular health may represent useful compounds that are able to reduce the overall cardiovascular risk induced by dyslipidaemia by acting parallel to statins or as adjuvants in case of failure or in situations where statins cannot be used. The mechanisms…

DyslipidaemiaMedicine (miscellaneous)Pharmacologychemistry.chemical_compoundPharmacotherapyNutraceuticalFunctional foodMedicineTX341-641Nutrition and DieteticsCholesterolbusiness.industryNutrition. Foods and food supplyStatinsnutritional and metabolic diseasesPatient preferenceCardiovascular diseaseschemistryMrna levelnutrizione; Nutraceuticallipids (amino acids peptides and proteins)NutraceuticalsDrug therapyFaecal excretionbusinessFood ScienceLipoprotein
researchProduct